4-ACETOXY-3-METHYL-2-[1(Z)-1-NONENYL]-QUINOLINE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	JYMBDXKPGVARBH-UVTDQMKNSA-N
Smiles	CCCCCCC\C=C/c1nc2ccccc2c(OC(=O)C)c1C
InChI	InChI=1S/C21H27NO2/c1-4-5-6-7-8-9-10-14-19-16(2)21(24-17(3)23)18-13-11-12-15-20(18)22-19/h10-15H,4-9H2,1-3H3/b14-10-

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C21H27NO2
Molecular Weight	325.44
AlogP	6.39
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	9.0
Polar Surface Area	39.19
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	24.0

Assay Description	Organism	Bioactivity
Insecticidal activity against Tetranychus urticae (two-spotted spider mite) eggs assessed as mortality at 1000 ppm by leaf spray method	Tetranychus urticae	100.0 %
Insecticidal activity against Tetranychus urticae (two-spotted spider mite) eggs assessed as mortality at 500 ppm by leaf spray method	Tetranychus urticae	100.0 %
Insecticidal activity against Tetranychus urticae (two-spotted spider mite) eggs assessed as mortality at 250 ppm by leaf spray method	Tetranychus urticae	68.2 %
Insecticidal activity against Laodelphax striatella (small brown planthopper) larvae assessed as mortality at 1000 ppm by leaf spray method	Laodelphax striatella	100.0 %
Insecticidal activity against Laodelphax striatella (small brown planthopper) larvae assessed as mortality at 500 ppm by leaf spray method	Laodelphax striatella	94.0 %
Insecticidal activity against Laodelphax striatella (small brown planthopper) larvae assessed as mortality at 250 ppm by leaf spray method	Laodelphax striatella	76.0 %
Insecticidal activity against Plutella xylostella (diamondback moth) larvae assessed as mortality at 1000 ppm by leaf spray method	Plutella xylostella	100.0 %
Insecticidal activity against Plutella xylostella (diamondback moth) larvae assessed as mortality at 500 ppm by leaf spray method	Plutella xylostella	100.0 %
Insecticidal activity against Plutella xylostella (diamondback moth) larvae assessed as mortality at 250 ppm by leaf spray method	Plutella xylostella	100.0 %
Insecticidal activity against Bombyx mori larvae assessed as mortality at 40 ug administered topically measured after 48 hr	Bombyx mori	100.0 %
Insecticidal activity against Bombyx mori larvae assessed as mortality at 10 ug administered topically measured after 48 hr	Bombyx mori	100.0 %
Insecticidal activity against Bombyx mori larvae assessed as mortality at 2.5 ug administered topically measured after 48 hr	Bombyx mori	100.0 %
Insecticidal activity against Bombyx mori larvae assessed as mortality at 0.63 ug administered topically measured after 48 hr	Bombyx mori	65.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2271248
SureChEMBL	SCHEMBL8134247

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).